Gefitinib

Nanog homeobox ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34145929 MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma. 2021 Sep 1
2 32428834 Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells. 2020 Jul 1
3 32820157 1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells. 2020 Aug 20 5